They are established medical facts supported by decades of human epidemiological data
"CagriSema Phase 3 REDEFINE Trial Results." Company press release and investor presentation
Clinical trials have shown that weekly doses of semaglutide can result in up to 10 percent weight loss within months, and 19 percent within six months
Key Allegations Against Novo Nordisk The crux of these lawsuits lies in allegations that Novo Nordisk, the manufacturer of Ozempic, was remiss in warning users about potential severe side effects, which include: Gastroparesis Concerns : Often termed stomach paralysis lawsuits, these claims assert that users were not adequately warned about the risk of delayed stomach emptying, a condition known as gastroparesis
4 Paradoxically, GIP-receptor knockout mice studies showed that, when fed a high-fat diet, the mice were resistant to weight gain
Common community options include adding cagrilintide for satiety, adding MOTS-c for mitochondrial support, or adding a GH secretagogue (covered in the Advanced Recomp Stack) for lean mass
